Literature DB >> 1976144

Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

M Steinbakk1, C F Naess-Andresen, E Lingaas, I Dale, P Brandtzaeg, M K Fagerhol.   

Abstract

The calcium binding L1 protein was found to inhibit growth of blood culture isolates of Candida spp and cerebrospinal fluid isolates of Cryptococcus neoformans. Minimum inhibitory concentrations (MIC) were 4-128 mg/l, and concentrations 2-4 times the MIC were fungicidal. Blood culture isolates of Escherichia coli, Klebsiella spp, Staphylococcus aureus, and Staphylococcus epidermidis had MIC values of 64-256 mg/l. Antibacterial activity was strongly influenced by the nature of the culture medium. In view of the biological activity of L1, the name calprotectin is proposed to describe this antimicrobial protein with calcium binding properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976144     DOI: 10.1016/0140-6736(90)93237-j

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  140 in total

Review 1.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

3.  Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

Authors:  M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1996-04

4.  Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Authors:  Sharof Tugizov; Jennifer Berline; Rossana Herrera; Maria Elena Penaranda; Mayumi Nakagawa; Joel Palefsky
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection.

Authors:  Tatiana Kisseleva; Maren von Köckritz-Blickwede; Donna Reichart; Shauna M McGillvray; Gerhard Wingender; Mitchell Kronenberg; Christopher K Glass; Victor Nizet; David A Brenner
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

6.  Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method.

Authors:  Seung-Wook Kim; Kyounga Cheon; Chang-Hoon Kim; Joo-Heon Yoon; David H Hawke; Ryuji Kobayashi; Ludmila Prudkin; Ignacio I Wistuba; Reuben Lotan; Waun Ki Hong; Ja Seok Koo
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

7.  Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Authors:  Zhuo Yang; Nick Clark; K T Park
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-21       Impact factor: 11.382

8.  Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors:  Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal:  Biomed Rep       Date:  2016-09-07

9.  Serum 27E10 antigen: a new potential marker for staging HIV disease.

Authors:  N Lügering; R Stoll; T Kucharzik; G Burmeister; C Sorg; W Domschke
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

10.  Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.

Authors:  Frank Serge Lehmann; Francesca Trapani; Ida Fueglistaler; Luigi Maria Terracciano; Markus von Flüe; Gieri Cathomas; Andreas Zettl; Pascal Benkert; Daniel Oertli; Christoph Beglinger
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.